(Q42596283)

3 November 2017

title

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study (English)

1 reference

3 November 2017

0 references

0 references

bronchiolitis obliterans

1 reference

Susan G Gerhardt

1

1 reference

3 November 2017

John F McDyer

2

1 reference

3 November 2017

Reda E Girgis

3

1 reference

3 November 2017

John V Conte

4

1 reference

3 November 2017

Stephen C Yang

5

1 reference

3 November 2017

Jonathan B Orens

6

1 reference

3 November 2017

language of work or name

English

0 references

publication date

2 April 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

3 November 2017

published in

1 reference

3 November 2017

volume

168

1 reference

3 November 2017

issue

1

1 reference

3 November 2017

page(s)

121-125

1 reference

Obliterative bronchiolitis after lung and heart-lung transplantation

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Chronic allograft rejection (obliterative bronchiolitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Bronchiolitis obliterans after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

The effect of antimicrobial agents on leukocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Chlamydia pneumoniae is associated with graft dysfunction after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

Possible interaction between intravenous azithromycin and oral cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200212-1424BC

10.1164/RCCM.200212-1424BC

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference